Importantly, the iron chelating agent deferomine (DFO) alleviates the pathological lesions including Aβ accumulation, hyperphosphorylation of tau, and behavioral disruption, in an iron-overloaded AD model (22, 23), which indicates the essential role of iron in the pathogenesis of AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.